Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business. Cigna ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

The Cigna Group reported $739 million in profit for the third quarter, a figure that accounts for a $1 billion after-tax ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

Cigna completed its combination with Express Scripts Holding Company by 2018-end. Shares of the new combined company trade on the NYSE under the stock ticker symbol “CI.” CI sits at a Zacks Rank #3 ...

Meanwhile, Cigna’s health services division Evernorth — which includes major pharmacy benefit manager Express Scripts — continues to reliably grow revenue. Evernorth “anchored” Cigna’s ...

Market Leadership in Pharmacy Benefit Management: The Cigna Group's merger with Express Scripts in 2018 significantly bolstered its pharmacy benefit management (PBM) and specialty pharmacy services.

A collaboration to enhance the readiness of healthcare clusters in the Kingdom in their transformation into newly-formed ...

PBM Express Scripts is following a similar path to the one taken by CVS Caremark. Starting in June, Evernorth, a division of ...

Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.